novel therapeutic approaches in bpdcn : targeting cd123 and beyond
Published 3 years ago • 392 plays • Length 33:25Download video MP4
Download video MP3
Similar videos
-
9:29
biology of bpdcn: understanding cd123
-
6:46
beyond bpdcn: cd123 – a therapeutic target in other hematologic malignancies
-
1:36
imgn632: a novel cd123-targeted antibody-drug conjugate for r/r bpdcn
-
3:45
imgn632: a novel cd123 adc for r/r aml and bpdcn
-
2:12
novel agents of interest for the treatment of bpdcn
-
37:31
blastic plasmacytoid dendritic cell neoplasm (bpdcn) - diagnosis and treatment
-
2:57
novel targeted therapies for the treatment of bpdcn
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
7:54
clinical presentation of bpdcn
-
1:33
the need for novel therapeutic agents in myeloproliferative neoplasms
-
23:41
novel therapeutic approaches in cll
-
27:36
novel therapies in myeloid neoplasms
-
2:05
the surpass-et study: evaluating novel treatment approaches in et
-
1:06:04
itp: novel treatments
-
0:35
novel therapeutics in essential thrombocythemia
-
0:42
the limited access to novel therapeutics for sickle cell disease in lmics
-
5:38
novel agents for bpdcn management
-
2:21
blastic plasmacytoid dendritic cell neoplasm